Stock Events

Stock Events

Mayne Pharma Group Limited 

$1.65
14
+$0.1+6.8% Wednesday 13:47

Statistics

Day High
1.65
Day Low
1.65
52W High
4.38
52W Low
1.63
Volume
10,000
Avg. Volume
949
Mkt Cap
134.06M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jan 23
$0.38
Mar 11
$0.2
Nov 10
$0.4
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

22FebExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.91
-0.61
-0.3
0.01
Expected EPS
-0.015042128103249074
Actual EPS
-0.14101995096796005

Financials

-23.32%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
524.95MRevenue
-122.43MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MAYNF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries Ltd. is a global leader in generic medicines, directly competing with Mayne Pharma in the generics market.
Perrigo Company
PRGO
Mkt Cap2.85B
Perrigo Company plc specializes in over-the-counter healthcare products, competing with Mayne Pharma in the consumer health market.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, competing with Mayne Pharma particularly in the pharmaceutical and consumer health products sectors.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a global pharmaceutical corporation that competes with Mayne Pharma in the development and distribution of both generic and specialty pharmaceuticals.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. is a research-based biopharmaceutical company that competes with Mayne Pharma in the development and marketing of pharmaceutical products, particularly in areas like dermatology.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc is a global healthcare company that competes with Mayne Pharma in the pharmaceutical and healthcare sectors, including areas such as respiratory diseases, vaccines, and consumer healthcare products.

About

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Show more...
CEO
Mr. Shawn Patrick O'Brien M.B.A., M.S.
Employees
450
Country
AU
ISIN
AU000000MYX0

Listings

AU
AU
MYX.AU
OTC Link
US
MAYNF
F
DE
HG6.F

0 Comments

Share your thoughts

FAQ

What is Mayne Pharma Group Limited stock price today?▼
The current price of MAYNF is $1.65 USD — it has increased by +6.8% in the past 24 hours. Watch Mayne Pharma Group Limited stock price performance more closely on the chart.
What is Mayne Pharma Group Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mayne Pharma Group Limited stocks are traded under the ticker MAYNF.
Is Mayne Pharma Group Limited stock price growing?▼
MAYNF stock has risen by +0.61% compared to the previous week, the month change is a -5.44% fall, over the last year Mayne Pharma Group Limited has showed a -62.29% decrease.
What is Mayne Pharma Group Limited market cap?▼
Today Mayne Pharma Group Limited has the market capitalization of 134.06M
When is the next Mayne Pharma Group Limited earnings date?▼
Mayne Pharma Group Limited is going to release the next earnings report on August 20, 2026.
What were Mayne Pharma Group Limited earnings last quarter?▼
MAYNF earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.01 USD resulting in a -837.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Mayne Pharma Group Limited revenue for the last year?▼
Mayne Pharma Group Limited revenue for the last year amounts to 524.95M USD.
What is Mayne Pharma Group Limited net income for the last year?▼
MAYNF net income for the last year is -122.43M USD.
Does Mayne Pharma Group Limited pay dividends?▼
Yes, MAYNF dividends are paid quarterly. The last dividend per share was 0.38 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Mayne Pharma Group Limited have?▼
As of April 02, 2026, the company has 450 employees.
In which sector is Mayne Pharma Group Limited located?▼
Mayne Pharma Group Limited operates in the Health Care sector.
When did Mayne Pharma Group Limited complete a stock split?▼
The last stock split for Mayne Pharma Group Limited was on January 18, 2023 with a ratio of 1:20.
Where is Mayne Pharma Group Limited headquartered?▼
Mayne Pharma Group Limited is headquartered in Salisbury South, AU.